Hirsh, J., O'Sullivan, E.F., and Martin, M.: Evaluation of a standard dosage schedule with streptokinase. Blood, 35: 341, 1970.
2.
Fletcher, A.P. , Alkjaersig, N., Sherry, S., Genton, E., Hirsh, J., and Bachman, F.: The development of urokinase as a thrombolytic agent: Maintenance of a sustained thromboembolic state in man by its intravenous infusion. J. Lab. Clin. Med., 65: 713, 1965.
3.
Sherry, S.: Fibrinolysis. Ann. Rev. Med.19: 247, 1968.
4.
Bruner-Lorand, J., and Pilkington , R.E.: Inhibitors of fibrin cross-linking: Relevance for thrombolysis. Nature, 210: 1273, 1966.
5.
Henderson, K.W. , and Nussbaum, M.: The mechanism of enhanced streptokinase-induced clot lysis following in-vitro Factor XIII inactivation. Br. J. Haematol., 17: 445, 1969.
6.
Feddersen, C. , and Gormsen, J.: Plasma digestion of stabilized and non-stabilized fibrin illustrated by pH-stat titration and thromboelastography. Scand. J. Clin. Lab. Invest., 27: 175, 1971.
7.
Alkjaersig, N. , Fletcher, A.P., and Sherry, S.: The mechanism of clot dissolution by plasmin . J. Clin. Invest., 38: 1086, 1959.
8.
Hedner, V., Nilsson, I.M., and Robertson, B.: Determination of plasminogen in clots and thrombi. Thromb. Diath. Haemorrh., 16: 38, 1966.
9.
Chesterman, C.N. , Allington, M.J., and Sharp, A.A.: Relationship of plasminogen activator to fibrin. Nature, 238: 15, 1972.
10.
Amery, A., Donati, M.B., Vermylen, J., and Verstraete, M.: Comparison between the changes in the plasma fibrinogen and plasminogen levels induced by a moderate or high initial dose of streptokinase. Thromb. Diath. Haemorrh., 23: 504, 1970.
11.
Ambrus, C.M., and Markus, G.: Plasmin-Antiplasmin complex as a reservoir of fibrinolytic enzymes. Am. J. Physiol.199: 491, 1960.
12.
Harpel, P.C. , and Mosesson, M.W.: Degradation of human fibrinogen by plasma α2 macroglobulin-enzyme complexes. J. Clin. Invest., 52:
13.
Jørgensen, L., Rowsell, H.C., Hovig, T., and Mustard, J.F.: Resolution and organization of platelet-rich mural thrombi in carotid arteries of swine. Am. J. Pathol. , 51: 681, 1967.
14.
Hirsh, J., Buchanan, M., Glynn, M.F., and Mustard, J.F.: Effect of activation of the fibrinolytic mechanism on experimental platelet-rich thrombi. J. Lab. Clin. Med., 72: 245, 1968.
15.
Fletcher, A.P. , Alkjaersig, N., and Sherry, S.: The maintenance of a sustained thrombolytic state in man. I. Induction and effects. J. Clin. Invest., 38: 1096, 1959.
16.
Fletcher, A.P. , Alkjaersig, N., and Sherry, S.: The clearance of heterologous protein from the circulation of normal and immunized man. J. Clin. Invest. , 37: 1306, 1958.
17.
Verstraete, M., Vermylen, M., Amery, A., and Vermylen, C.: Thrombolytic therapy with streptokinase using a standard dosage scheme. Br. Med. J., 1: 454, 1966.
18.
Fletcher, A.P. , Alkjaersig, M., and Sherry, S.: Fibrinolytic mechanisms and the development of thrombolytic therapy. Am. J. Med., 33: 738, 1962.
19.
Hirsh, J., Hale, G., MacDonald, I., McCarthy, R., and Pitt, A.: Streptokinase therapy in acute major pulmonary embolism: Effectiveness and problems. Br. Med. J., 21: 729, 1968.
20.
Hirsh, J., McDonald, I., and O'Sullivan, E.: Comparison of the effects of streptokinase and heparin on the early rate of resolution of major pulmonary embolism. Can. Med. Assoc. J. , 104: 488 & 516, 1971.
21.
Miller, G., Sutton, G., Kerr, I., Gibson, R., and Honey, M.: Comparison of streptokinase and heparin in treatment of isolated acute massive pulmonary embolism. Br. Med. J., 2: 681, 1971.
Tow, D., Wagner, H., Jr., and Holmes, R.: Urokinase in pulmonary embolism. N. Engl. J. Med., 277:1161, 1967.
24.
Donald, G.A. , Williams, G., Scannell, J.G., and Shaw, R.S.: A reappraisal of the application of the Trendelenburg operation to massive fetal pulmonary embolism. N. Engl. J. Med., 268: 171, 1963.
25.
Chait, A., Summers, D., Krasinow, N., and Wechsler, B.M.: Observations on the fate of large pulmonary emboli. Am. J. Roentgenol., 100: 364, 1967.
26.
Kakkar, V., Flanc, C., Howe, C., O'Shea, M., and Flute, P.: Treatment of deep vein thrombosis: A trial of heparin, streptokinase and Arvin . Br. Med. J., 1: 806, 1969.
27.
Kakkar, V., Flanc, C., O'Shea, M., Flute, P., Howe, C., and Clarke, M.: Treatment of deep vein thrombosis with streptokinase. Br. J. Surg., 56: 178, 1969.
28.
Schmutzler, R. , and Koller, F.: Thrombolytic therapy. In: Poller, L. (ed.), Recent Advances in Blood Coagulation, p. 299. Little, Brown, Boston, 1969.
29.
Salmon, J.: Fibrinolyse et Pathologie Vasculaire, p. 207. Arscia, S., Bruxelles and Maloine, S. (eds.), Paris, 1964.
30.
Verstraete, M., Amery, A., and Vermylen, J.: Feasibility of adequate thrombolytic therapy with streptokinase and peripheral arterial occlusions. I. Clinical and arteriographic results. Br. Med. J., 1: 1499, 1963.
31.
Verstraete, M., Vermylen, J., and Donati, M.: The effect of streptokinase infusion on chronic arterial occlusions and stenoses. Ann. Intern. Med., 74: 377, 1971.
32.
Hirsh, J., O'Sullivan, E.F., Gallus, A.S., and Gilford, E.J.: Arterial thrombosis in a patient with chronic thrombocytopenia: Successful treatment with intra-arterial infusion of streptokinase. Med. J. Aust., 2: 1304, 1969.
33.
Gallus, A.S., and Hirsh, J.: Combined use of low dose streptokinase and full dose heparin. Proceedings of the Fifteenth Congress of the International Society of Hematology, Jerusalem, (In press) 1974.
34.
Sherry, S.: Streptokinase therapy for thromboembolic vascular occlusive vascular disease . Ann. Intern. Med., 74: 437, 1971.